These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11220296)

  • 1. Glucose and fatty acid metabolism in type 2 diabetes mellitus: an assessment using low-dose insulin infusion and the hyperinsulinaemic euglycaemic clamp.
    Webber J; Whitelaw D; Smith JM; Nattrass M
    Diabetes Obes Metab; 1999 May; 1(3):173-8. PubMed ID: 11220296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.
    Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Eriksson J; Taskinen MR
    Diabet Med; 1993 Dec; 10(10):950-7. PubMed ID: 8306591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid metabolism and insulin resistance in cirrhosis.
    Kaye GL; Kruszynska YT; Harry DS; Heslop K; Johnston DG; McIntyre N
    J Hepatol; 1994 Jun; 20(6):782-91. PubMed ID: 7930479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?
    Staehr P; Hojlund K; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabet Med; 2003 Oct; 20(10):816-22. PubMed ID: 14510862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp.
    Hordern SV; Wright JE; Umpleby AM; Shojaee-Moradie F; Amiss J; Russell-Jones DL
    Diabetologia; 2005 Mar; 48(3):420-6. PubMed ID: 15729576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty.
    Arslanian SA; Kalhan SC
    Diabetes; 1994 Jul; 43(7):908-14. PubMed ID: 8013756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body glucose metabolism in obese patients with type 2 diabetes mellitus: the impact of hypertension and strict blood glucose control.
    Vestergaard H; Parving HH; Hansen L; Pedersen O
    Diabet Med; 1995 Feb; 12(2):156-63. PubMed ID: 7743763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).
    Vaag A; Lehtovirta M; Thye-Rönn P; Groop L;
    Diabet Med; 2001 Jul; 18(7):533-40. PubMed ID: 11553181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hyperinsulinaemic-euglycaemic glucose clamp: reproducibility and metabolic effects of prolonged insulin infusion in healthy subjects.
    Soop M; Nygren J; Brismar K; Thorell A; Ljungqvist O
    Clin Sci (Lond); 2000 Apr; 98(4):367-74. PubMed ID: 10731469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
    Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
    Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia.
    Monti LD; Brambilla P; Stefani I; Caumo A; Magni F; Poma R; Tomasini L; Agostini G; Galli-Kienle M; Cobelli C
    Diabetologia; 1995 Jun; 38(6):739-47. PubMed ID: 7672499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.
    Torlone E; Rambotti AM; Perriello G; Botta G; Santeusanio F; Brunetti P; Bolli GB
    Diabetologia; 1991 Feb; 34(2):119-25. PubMed ID: 2065846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.
    Schauer IE; Snell-Bergeon JK; Bergman BC; Maahs DM; Kretowski A; Eckel RH; Rewers M
    Diabetes; 2011 Jan; 60(1):306-14. PubMed ID: 20978091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
    Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
    Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.
    Rebrin K; Steil GM; Getty L; Bergman RN
    Diabetes; 1995 Sep; 44(9):1038-45. PubMed ID: 7657026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.